April 18, 2020 Central Drugs Standard Control Organization (CDSCO), the Government of India Drug Regulatory Agency has permitted the conduct of clinical trial of Convalescent Plasma In COVID-19 Patients. The trial protocol was developed and submitted by Indian Council of…
Recent Post
- CDSCO Issues Public Notice on Disposal of Long-Pending SUGAM Applications
- India Bans High-Dose Nimesulide: What You Need to Know
- Compounding of Offences under the Drugs and Cosmetics Act, 1940: What Stakeholders Need to Know
- 🚨 CDSCO Directive on Immediate Inspections as per Revised Schedule M – Is Your Facility Ready?
- CDSCO Issues Regulatory Clarification on Combi-Pack Approvals: Key Insights for Injectable Manufacturers
